Breaking News
Sort by:
Top Post
EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis
EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China
TaiGen Biotechnology Company announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical […]
Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease
Roche announced today that it has entered into a collaboration with Eli Lilly and Company […]
Dupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis
Regeneron Pharmaceuticals and Sanofi today announced that the European Commission (EC) has approved Dupixent (dupilumab) […]
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
CHARM Therapeutics, a 3D deep learning biotechnology company discovering and developing transformational medicines, today announced […]
RVAC Medicines Announces Research Collaboration with University of Pennsylvania
RVAC Medicines, a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has […]
Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01
Leap Therapeutics, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that […]
Synaffix Announces Expansion of ADC Collaboration with MacroGenics
Synaffix, a biotechnology company focused on commercializing its clinical-stage platform technology for the development of […]
Leucid Bio and Great Ormond Street Hospital Enter Commercial Agreement at New Gene Therapy Manufacturing Centre
Leucid Bio, a biotech company pursuing a differentiated approach to develop next-generation Chimeric Antigen Receptor […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more